Schizophrenia Studies Find Genetic Risk Spread Across Shared Pathways | GenomeWeb

NEW YORK (GenomeWeb News) – A pair of papers published online today in Nature described the outcome of two large exome sequencing studies aimed at finding new and/or rare genetic contributors to schizophrenia.

In each case, the groups involved found that schizophrenia risk did not reside in any one gene, but across a few, recurrent — often brain-related — pathways.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.